Jordan · Delayed Price · Currency is JOD General Investment Statistics
Total Valuation
ASE:GENI has a market cap or net worth of JOD 26.20 million. The enterprise value is 24.55 million.
| Market Cap | 26.20M |
| Enterprise Value | 24.55M |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Apr 23, 2026 |
Share Statistics
ASE:GENI has 10.00 million shares outstanding. The number of shares has decreased by -0.65% in one year.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 19.30% |
| Owned by Institutions (%) | 5.98% |
| Float | 2.67M |
Valuation Ratios
The trailing PE ratio is 12.40.
| PE Ratio | 12.40 |
| Forward PE | n/a |
| PS Ratio | 2.20 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | 1,592.90 |
| P/OCF Ratio | 51.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.37, with an EV/FCF ratio of 1,492.55.
| EV / Earnings | 11.54 |
| EV / Sales | 1.95 |
| EV / EBITDA | 11.37 |
| EV / EBIT | 13.81 |
| EV / FCF | 1,492.55 |
Financial Position
The company has a current ratio of 5.51
| Current Ratio | 5.51 |
| Quick Ratio | 2.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.99% and return on invested capital (ROIC) is 4.70%.
| Return on Equity (ROE) | 6.99% |
| Return on Assets (ROA) | 3.40% |
| Return on Invested Capital (ROIC) | 4.70% |
| Return on Capital Employed (ROCE) | 5.39% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 86,859 |
| Profits Per Employee | 15,522 |
| Employee Count | n/a |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, ASE:GENI has paid 378,753 in taxes.
| Income Tax | 378,753 |
| Effective Tax Rate | 15.12% |
Stock Price Statistics
The stock price has decreased by -11.19% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.19% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 34.76 |
| Average Volume (20 Days) | 5,549 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASE:GENI had revenue of JOD 11.90 million and earned 2.13 million in profits. Earnings per share was 0.21.
| Revenue | 11.90M |
| Gross Profit | 4.39M |
| Operating Income | 1.78M |
| Pretax Income | 2.51M |
| Net Income | 2.13M |
| EBITDA | 2.15M |
| EBIT | 1.78M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 444,440 in cash and n/a in debt, with a net cash position of 444,440 or 0.04 per share.
| Cash & Cash Equivalents | 444,440 |
| Total Debt | n/a |
| Net Cash | 444,440 |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 33.05M |
| Book Value Per Share | 3.33 |
| Working Capital | 9.45M |
Cash Flow
In the last 12 months, operating cash flow was 508,859 and capital expenditures -492,411, giving a free cash flow of 16,448.
| Operating Cash Flow | 508,859 |
| Capital Expenditures | -492,411 |
| Depreciation & Amortization | 364,618 |
| Net Borrowing | n/a |
| Free Cash Flow | 16,448 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 36.93%, with operating and profit margins of 14.97% and 17.87%.
| Gross Margin | 36.93% |
| Operating Margin | 14.97% |
| Pretax Margin | 21.05% |
| Profit Margin | 17.87% |
| EBITDA Margin | 18.03% |
| EBIT Margin | 14.97% |
| FCF Margin | 0.14% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.58%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 4.58% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 56.12% |
| Buyback Yield | 0.65% |
| Shareholder Yield | 5.23% |
| Earnings Yield | 8.12% |
| FCF Yield | 0.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |